Gde2KO mice show an age-progressive neurodegeneration and gliosis indicative of increased inflammation, and GDE2 distribution and function are shown to be disrupted in AD, ALS, and ALS/FTD [23,26,27]. Here, GDPD5 is linked to Alzheimer disease.